Halozyme Therapeutics

HALO

HALO
Halozyme Therapeutics Stock Quote
$28.93 -$0.86 -2.9%
Price as of October 28, 2020, 8:00 p.m. EDT View Interactive HALO Charts

A biopharmaceutical company dedicated to the development and commercialization of recombinant human enzymes for the drug delivery, palliative care, oncology and infertility markets.

Interactive Chart


News & Analysis: Halozyme Therapeutics

The Fool has written over 100 articles on Halozyme Therapeutics.

All

Market Moves

Earnings